• Thumbnail for CanSino Biologics
    39°04′26″N 117°32′35″E / 39.0739°N 117.5430°E / 39.0739; 117.5430 CanSino Biologics (simplified Chinese: 康希诺生物; traditional Chinese: 康希諾生物; pinyin: Kāngxīnuò...
    19 KB (1,263 words) - 20:09, 26 December 2024
  • include Gan & Lee (SSE:603087), Cansino Biologics (SSE:688185; HKSE:6185), SinoCellTech (SSE:688520), Sino Biological (SZSE:301047), Schrödinger (NASDAQ:SDGR)...
    8 KB (783 words) - 05:36, 28 November 2024
  • Thumbnail for Convidecia
    COVID-19 that is also used as an inhaled booster. It was developed by CanSino Biologics, with Phase III trials conducted in Argentina, Chile, Mexico, Pakistan...
    36 KB (3,363 words) - 15:13, 13 December 2024
  • The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of...
    13 KB (1,525 words) - 23:42, 4 September 2024
  • Sputnik V by the Gamaleya Institute (February 2, 2021) Ad5-nCoV by CanSino Biologics Inc. (February 9, 2021) CoronaVac by Sinovac Research and Development...
    10 KB (796 words) - 15:33, 1 January 2024
  • Thumbnail for Justin Trudeau
    reached an exclusive deal with CanSino Biologics. However, due to deteriorating Canadian-Chinese relations, the Cansino deal fell through. On August 5...
    239 KB (19,578 words) - 06:21, 26 December 2024
  • Thumbnail for Chen Wei (medical scientist)
    Institute of Biotechnology, the Academy of Military Medical Sciences, and CanSino Biologics to develop Convidecia. The development team registered a Phase 1 trial...
    15 KB (1,083 words) - 19:10, 12 September 2024
  • Thumbnail for Sinopharm (company)
    COVID-19 vaccine is also an inactivated virus vaccine.[citation needed] CanSino Biologics Sinovac "中国医药集团有限公司主要领导调整" (in Chinese). Sinopharm. Archived from...
    17 KB (1,214 words) - 18:37, 20 October 2024
  • Thumbnail for Academy of Military Medical Sciences
    Uyghurs in China. During the COVID-19 pandemic, the AMMS partnered with CanSino Biologics to develop Convidecia. The development team, led by Chen Wei, registered...
    12 KB (1,008 words) - 18:05, 12 September 2024
  • Thumbnail for History of COVID-19 vaccine development
    October 2022, China began administering an oral vaccine developed by CanSino Biologics using its adenovirus model. Despite the availability of mRNA and viral...
    122 KB (11,033 words) - 06:12, 17 November 2024
  • Thumbnail for Vaccine diplomacy
    Foreign Affairs of Mexico Marcelo Ebrard announced agreements with CanSino Biologics and Walvax to conduct clinical trials for vaccines from China, with...
    40 KB (3,690 words) - 08:20, 8 November 2024
  • authorizes use of China's CanSino vaccine against COVID-19". Reuters. 15 June 2021. Retrieved 16 June 2021. "China's CanSino Biologics COVID-19 vaccine receives...
    322 KB (19,558 words) - 03:15, 23 November 2024
  • Thumbnail for Responses to the COVID-19 pandemic in June 2021
    Jamaluddin confirmed that refugee communities in Malaysia would receive CanSino Biologics' Convidecia vaccine; with the first shipment due to arrive in late...
    20 KB (1,657 words) - 06:45, 20 November 2024
  • Thumbnail for COVID-19
    the original on 30 January 2021. Retrieved 21 December 2020. "The CanSino Biologics Ad5-nCoV-S [recombinant] COVID-19 vaccine: What you need to know"...
    288 KB (33,201 words) - 15:09, 26 December 2024
  • Thumbnail for COVID-19 vaccination in Mexico
    the vaccine. The COVID-19 vaccine from the pharmaceutical company CanSino Biologics will be packaged in Querétaro, after the company requested from COFEPRIS...
    16 KB (1,162 words) - 20:33, 16 May 2024
  • Thumbnail for Sinovac Biotech
    unethically endangered innocent lives for potential geopolitical gain. CanSino Biologics Sinopharm "China's Vaccine Front-Runner Aims to Beat Covid the Old-Fashioned...
    29 KB (2,012 words) - 15:24, 3 December 2024
  • October 2022, China began administering an oral vaccine developed by CanSino Biologics using its adenovirus model. Despite the availability of mRNA and viral...
    207 KB (23,491 words) - 07:01, 23 December 2024
  • Thumbnail for COVID-19 vaccination in Canada
    conduct clinical trials of a vaccine candidate by Chinese company CanSino Biologics, and plans to manufacture it at its facilities in Montreal once authorized...
    185 KB (14,787 words) - 04:28, 26 July 2024
  • reached an exclusive deal with CanSino Biologics. However, due to deteriorating Canadian-Chinese relations, the Cansino deal fell through. On August 5...
    124 KB (13,838 words) - 15:10, 17 December 2024
  • Thumbnail for COVID-19 pandemic in Pakistan
    approved the emergency use of the Convidecia vaccine developed by CanSino Biologics. On 24 February 2021, Pakistan announced all coronavirus restrictions...
    191 KB (18,699 words) - 23:01, 2 December 2024
  • Thumbnail for COVID-19 pandemic
    vaccine was introduced, developed by Chinese biopharmaceutical company CanSino Biologics, in the city of Shanghai, China. For the first two years of the pandemic...
    368 KB (32,708 words) - 00:42, 16 December 2024
  • Thumbnail for COVID-19 pandemic in Canada
    conduct clinical trials of a vaccine candidate by Chinese company CanSino Biologics, and plans to manufacture it at its facilities in Montreal once authorized...
    175 KB (14,698 words) - 05:57, 27 September 2024
  • Thumbnail for Ebola vaccine
    Academy of Military Medical Sciences and the private vaccine-maker CanSino Biologics. It contains a human adenovirus serotype 5 vector (Ad5) with the glycoprotein...
    67 KB (6,243 words) - 08:59, 30 September 2024
  • Thumbnail for Chinese government response to COVID-19
    Biotech Group. The government also approved a vaccine developed by CanSino Biologics for use in the military. By mid-December, authorities said that over...
    188 KB (20,066 words) - 21:10, 27 October 2024
  • Thumbnail for COVID-19 vaccination in Singapore
    Partially approved unknown 3 November 2021 (EUA) Pending Bharat Biotech - Convidecia Partially approved unknown 19 May 2022 (EUA) Pending CanSino Biologics -...
    39 KB (2,991 words) - 18:32, 30 November 2024
  • Thumbnail for COVID-19 vaccination in Malaysia
    confirmed that refugee communities in Malaysia would be inoculated with CanSino Biologics' Convidecia vaccine. The first shipment is due to arrive in late July...
    329 KB (29,678 words) - 20:53, 17 December 2024
  • Thumbnail for Responses to the COVID-19 pandemic in August 2020
    developed by American company Johnson & Johnson and Chinese companies CanSino Biologics and Walvax Biotechnology, with the aim of eventually securing doses...
    139 KB (12,846 words) - 06:41, 20 November 2024
  • Thumbnail for Romani people
    Roma. Antonio Cansino blended Romani and Spanish flamenco and is credited with creating modern-day Spanish dance. The Dancing Cansinos popularized flamenco...
    216 KB (20,543 words) - 01:13, 26 December 2024
  • Thumbnail for Vaccine trial
    [page needed] Research, Center for Biologics Evaluation and. "Biologics License Applications (BLA) Process (Biologics) – Vaccine Product Approval Process"...
    11 KB (1,189 words) - 08:25, 2 July 2024
  • Thumbnail for KD-414
    COVID-19 vaccine candidate developed by Japanese biotechnology company KM Biologics Co. Results of a phase 1/2 clinical trial for this vaccine were released...
    4 KB (248 words) - 09:19, 30 December 2023